Capstone Capital Management Ltd purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 2,653 shares of the company’s stock, valued at approximately $944,000.
A number of other large investors also recently added to or reduced their stakes in the business. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs during the 2nd quarter worth approximately $25,000. Archer Investment Corp bought a new stake in shares of Astera Labs during the second quarter worth approximately $30,000. Transamerica Financial Advisors LLC bought a new stake in shares of Astera Labs during the second quarter worth approximately $35,000. Continuum Advisory LLC acquired a new position in Astera Labs in the second quarter valued at approximately $37,000. Finally, GK Wealth Management LLC acquired a new position in Astera Labs in the third quarter valued at approximately $29,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares in the company, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the sale, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock worth $127,306,034 in the last quarter. 10.40% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Several research analysts have recently issued reports on the company. Needham & Company LLC raised their price target on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Morgan Stanley upped their price objective on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Jefferies Financial Group increased their target price on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Bank of America raised their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a report on Tuesday, June 23rd. Finally, Weiss Ratings upgraded Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $344.17.
Read Our Latest Stock Report on ALAB
Astera Labs Price Performance
Shares of Astera Labs stock opened at $284.80 on Wednesday. The firm has a market cap of $49.41 billion, a price-to-earnings ratio of 140.99 and a beta of 3.68. The stock’s 50-day moving average is $313.70 and its 200-day moving average is $300.89. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 2.70 EPS for the current year.
Astera Labs Profile
Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.
Recommended Stories
- Five stocks we like better than Astera Labs
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
